Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Identification of drug leads against HCV and malaria using different target proteins
Hepatitis C Virus (HCV) infects 170 million individuals worldwide. Although several newly FDA approved drugs targeting the HCV serine protease and polymerase have shown promising results, there is a need for better drugs that are effective in treating all HCV genotypes and subtypes to be used in an...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
AUC Knowledge Fountain
2014
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Identification of drug leads against HCV and malaria using different target proteins
- Identification of T-cell epitopes in the Hepatitis C virus genotype 4 proteome: a step towards epitope-driven vaccine development
- Epidemiology, molecular characterisation and tropism of the Hepatitis G Virus / GBV-C
- Seroprevalence and factors associated with hepatitis C coinfection among HIV-positive pregnant women at the University College Hospital, Ibadan, Nigeria
- A real-time reverse transcription polymerase chain reaction for the sensitive detection of hepatitis a virus in various clinical and environmental samples
- INCIDENCE OF HEPATITIS C VIRUS INFECTION IN A SEMI-URBAN COMMUNITY OF SOUTHWESTERN NIGERIA
- Serum Hepatitis C virus and hepatitis B surface antigenaemia patients with acute icteric hepatitis